bivalirudin (Sandoz)


Welcome to the PulseAid listing for the bivalirudin drug offered from Sandoz. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz
NON-PROPRIETARY NAME: bivalirudin
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00


bivalirudin HUMAN PRESCRIPTION DRUG Details:

Item Descriptionbivalirudin from Sandoz
LABELER NAME: Sandoz
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3158_1a07a375-7456-4e00-befe-07aaf2cdb4a3
PRODUCT NDC: 0781-3158
APPLICATION NUMBER: NDA020873

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax